QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results
November 14, 2023 08:30 ET
|
QHSLab, Inc.
25% Y-O-Y Revenue Growth in Q3 2023 Compared to Q3 2022 and 51% Increase in Gross Profit. ●In Q3 2023, QHSLab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from...
Bright Mountain Media, Inc Announces Third Quarter Financial Results - Updated
November 14, 2022 15:58 ET
|
Bright Mountain Media, Inc.
Successful third quarter coupled with revenue growth Revenue increased 38% to $5.2 million compared to the third quarter 2021.Gross margin was $2.1 million growing 2% as compared to the third...
Bright Mountain Media, Inc Announces Third Quarter Financial Results
November 14, 2022 08:25 ET
|
Bright Mountain Media, Inc.
Successful third quarter coupled with revenue growth ■Revenue increased 38% to $5.2 million compared to the third quarter 2021. ■Gross margin was $2.1 million growing 2% as compared to the...
Worksport Reports 2021 Third Quarter Financial Results and Provides Business Update
November 15, 2021 10:16 ET
|
Worksport Ltd
Mississauga, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Worksport Ltd (Nasdaq-CM: WKSP) (the “Company”) reported financial results for the 2021 third quarter period ended September 30, 2021. Investors are...
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development Programs and Milestones
November 15, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
Submitted pre-IND briefing package to the FDA for intranasal/pulmonary CDI-45205 for the treatment of COVID-19 and sets goal of initiating IND-enabling study and Phase 1 in 2022Advance oral COVID-19...
mPhase Technologies Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
May 19, 2021 08:30 ET
|
mPhase Technologies, Inc.
Company Reports Fifth Consecutive Quarter of Profitability; Fortifies Balance Sheet to Pursue 5G and EV Charging Opportunities Gaithersburg, MD, May 19, 2021 (GLOBE NEWSWIRE) -- mPhase...
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
November 07, 2019 07:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Phase 3 “RESOLVE-1” study of lenabasum for treatment of systemic sclerosis on track for topline results in summer of 2020Systemic sclerosis is a rare autoimmune disease affecting ~200,000 people in...
MamaMancini’s Reports Fiscal 2019 Third Quarter Financial Results
December 11, 2018 16:15 ET
|
MamaMancini's Holdings, Inc.
Record Sales and Net Income in Q3 Q3 Revenue Up 12%; $8.2 million vs. $7.4 millionOperating Income More Than Doubles to $536,000 vs. $258,000Net Income Up 12x to $356,000 vs. Net Income of $29,000Cash...